Cryolipolysis for fat reduction using Cooltech® Define technology: A large-sample retrospective clinical study.
Cooltech® Define
body contouring
cryolipolysis
localized fat reduction
noninvasive
Journal
Journal of cosmetic dermatology
ISSN: 1473-2165
Titre abrégé: J Cosmet Dermatol
Pays: England
ID NLM: 101130964
Informations de publication
Date de publication:
Nov 2023
Nov 2023
Historique:
received:
07
08
2023
accepted:
21
08
2023
medline:
23
11
2023
pubmed:
1
9
2023
entrez:
1
9
2023
Statut:
ppublish
Résumé
Cryolipolysis is a noninvasive technique for localized fat reduction, which induces selective apoptosis of the adipocytes using controlled exposure to intense cold. During the past 10 years, this technique has been shown to be safe and effective and its application has significantly increased. In this context, Cooltech® devices have been widely used around the world. The purpose of this retrospective study was to evaluate the efficacy and safety of the removal of localized fatty tissue in different body areas using the new Cooltech® Define controlled cooling system. This single-center study was carried out on 287 patients, both female and male, treated with Cooltech® Define on different body areas for a total of 1118 procedures. Follow-up evaluations were conducted to estimate efficacy and safety. Efficacy was evaluated through plicometry and photographs. Side effects were also reported. Fold thickness showed a significant reduction (-69.91 ± 12.55%) after cryolipolysis treatment (fold thickness before: 35.33 ± 8.41 mm; fold thickness after: 10.69 ± 5.27 mm). Few side effects were reported, they included posttreatment pain (1.70%) and one case of paradoxical adipose hyperplasia (0.09%). The Cooltech® Define cryolipolysis device is a safe, effective, and well-tolerated nonsurgical procedure for reducing localized fat.
Sections du résumé
BACKGROUND
BACKGROUND
Cryolipolysis is a noninvasive technique for localized fat reduction, which induces selective apoptosis of the adipocytes using controlled exposure to intense cold. During the past 10 years, this technique has been shown to be safe and effective and its application has significantly increased. In this context, Cooltech® devices have been widely used around the world.
AIMS
OBJECTIVE
The purpose of this retrospective study was to evaluate the efficacy and safety of the removal of localized fatty tissue in different body areas using the new Cooltech® Define controlled cooling system.
METHODS
METHODS
This single-center study was carried out on 287 patients, both female and male, treated with Cooltech® Define on different body areas for a total of 1118 procedures. Follow-up evaluations were conducted to estimate efficacy and safety. Efficacy was evaluated through plicometry and photographs. Side effects were also reported.
RESULTS
RESULTS
Fold thickness showed a significant reduction (-69.91 ± 12.55%) after cryolipolysis treatment (fold thickness before: 35.33 ± 8.41 mm; fold thickness after: 10.69 ± 5.27 mm). Few side effects were reported, they included posttreatment pain (1.70%) and one case of paradoxical adipose hyperplasia (0.09%).
CONCLUSION
CONCLUSIONS
The Cooltech® Define cryolipolysis device is a safe, effective, and well-tolerated nonsurgical procedure for reducing localized fat.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
15-24Informations de copyright
© 2023 The Authors. Journal of Cosmetic Dermatology published by Wiley Periodicals LLC.
Références
Kennedy J, Verne S, Griffith R, Falto-Aizpurua L, Nouri K. Non-invasive subcutaneous fat reduction: a review. J Eur Acad Dermatol Venereol. 2015;29(9):1679-1688. doi:10.1111/jdv.12994
Pennycook K, Lamchak D, Julian C. Cryolipolysis-An update. Dermatol Rev. 2020;1:118-122. doi:10.1002/der2.46
Derrick CD, Shridharani SM, Broyles JM. The safety and efficacy of cryolipolysis: a systematic review of available literature. Aesthet Surg J. 2015;35(7):830-836. doi:10.1093/asj/sjv039
Bernstein EF. Longitudinal evaluation of cryolipolysis efficacy: two case studies. J Cosmet Dermatol. 2013;12:149-152. doi:10.1111/jocd.12036
US Food and Drug Administration 510(k) clearance K080521. 2010. Accessed August 1, 2023. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf8/K080521.pdf
US Food and Drug Administration 510(k) clearance K120023. 2012. Accessed August 1, 2023. Available from: https://www.accessdata.fda.gov/cdrh_docs/pdf8/K120023.pdf
Viera Mármol G, Ded Los Llanos M, Oliva J, Giménez C. Efficacy and safety of subcutaneous fat reduction by cryoadipolysis. IRJPMS. 2019;2(3):38-43.
Viera Mármol G, García P, Villena J. Validation of cooling and freezing dynamics of Cooltech® using an experimentally adjusted physical model. SASJM. 2017;3(12):343-349. doi:10.21276/sasjm.2017.3.12.7
Villena García J, Viera Mármol G, Cano Ochoa C, et al. Preliminary clinical validation of cryoadipolysis treatment under effects of ischemia simulated by COMSOL Multiphysics® software. Aesthet Med. 2020;6(4):30-35.
Fajardo Urdiales C, Ceres Ruiz L, Mellado Soria JM, Vélez González M, Viera MG. Assessing the efficacy of cryoadipolysis with the Cooltech® system: case study. EJMI. 2019;4(1):126-133. doi:10.14744/ejmi.2019.33025
Vélez González M, Castro D, Fajardo Urdiales C, De Los Llanos Pérez M, Mármol GV. Study on the reduction of the localized panniculus adiposus (adipocyte lysis) through the use of a controlled cooling system. IRJPMS. 2019;2(5):4-9.
Naranjo Garcia P, Lopez Andrino R, Pinto H. Treatment of localized adiposities through the combined use of lipocryolysis and biological detergent. Am J Surg. 2015;3(1-1):25-27. doi:10.11648/j.js.s.2015030101.18
Viera Mármol G, Villen J. New Cooltech Define® cryoadipolysis applicators: a scientific and comparative study with Cooltech® applicators. EJMI. 2019;3(2):85-94. doi:10.14744/ejmi.2019.35267
Viera Mármol G, Cano Ochoa C, De Los Llanos Pérez M, et al. Safety, efficacy and patient tolerance of the new 360° cryoadipolysis device for multiple-area fat removal. EJMI. 2019;4(1):41-50. doi:10.14744/ejmi.2019.82298
Singh SM, Geddes ERC, Boutrous SG, Galiano RD, Friedman PM. Paradoxical adipose hyperplasia secondary to cryolipolysis: an underreported entity? Lasers Surg Med. 2015;47(6):476-478.
Hedayati B, Juhasz M, Chu S, Atanaskova MN. Adverse events associated with cryolipolysis: a systematic review of the literature. Dermatol Surg. 2020;46:S8-S13. doi:10.1097/DSS.0000000000002524
Ho D, Jagdeo J. Systematic review of paradoxical adipose hyperplasia (PAH) post-cryolipolysis. J Drugs Dermatol. 2017;16(1):62-67.
Nikolis A, Enright KM. A multicenter evaluation of paradoxical adipose hyperplasia following cryolipolysis for fat reduction and body contouring: a review of 8658 cycles in 2114 patients. Aesthet Surg J. 2021;41(8):932-941. doi:10.1093/asj/sjaa310
Jalian HR, Avram MM, Garibyan L, Mihm MC, Anderson RR. Paradoxical adipose hyperplasia after cryolipolysis. JAMA Dermatol. 2014;150(3):317-319.
Kelly E, Rodriguez-Feliz J, Kelly ME. Paradoxical adipose hyperplasia after cryolipolysis: a report on incidence and common factors identified in 510 patients. Plast Reconstr Surg. 2016;137(3):639e-640e.
Stroumza N, Gauthier N, Senet P, Moguelet P, Nail Barthelemy R, Atlan M. Paradoxical adipose hypertrophy (PAH) after cryolipolysis. Aesthet Surg J. 2018;38(4):411-417.
Meyer PF, Davi Costa E, Silva J, Santos de Vasconcellos L, de Morais CE, Valentim da Silva RM. Cryolipolysis: patient selection and special considerations. Clin Cosmet Investig Dermatol. 2018;16(11):499-503. doi:10.2147/CCID.S146258